Ambev (ABEV) Releases Q3 2025 Financial Results

Ambev S.A. (NYSE:ABEV) is one of the Best Low Priced Stocks to Buy According to Analysts. On October 30, the company released its Q3 2025 financial results, with net revenue (organic) witnessing a rise of 1.2% compared to the last year. The top line performance was supported by net revenue per hectoliter (“NR/hl”) growth of 7.4%. The disciplined execution of Ambev S.A. (NYSE:ABEV)’s strategy strengthened its brands, contributing to resilient net revenue per hectoliter performance, as well as EBITDA growth with margin expansion.

Ambev S.A. (NYSE:ABEV) stated that its normalized EBITDA rose by 2.9%, with margin expanding 50 basis points, thanks to disciplined cost as well as expense management and efficient resource allocation. In Q3 2025, its normalized profit rose 7.4% as compared to R$3,579.6 million in Q3 2024, thanks to the lower income tax expenses, which were partially mitigated by increased net financial results.

During the first 9 months, Ambev S.A. (NYSE:ABEV)’s performance exhibited continued strengthening of its brands, with topline rising by 3.7%, thanks to the revenue management strategy and ongoing premiumization. On a YTD perspective, the company remains optimistic about its decisions and the resilience of the business.

While we acknowledge the potential of ABEV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now

Disclosure: None. This article is originally published at Insider Monkey.